{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:23:02Z","timestamp":1793726582734,"version":"4.6.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019673","name":"Bilimsel Ara\u015ft\u0131rma Projeleri Birimi, \u0130stanbul Teknik \u00dcniversitesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019673","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010760","name":"Van Yuzuncu Yil University","doi-asserted-by":"publisher","award":["TSA-2024-11274"],"award-info":[{"award-number":["TSA-2024-11274"]}],"id":[{"id":"10.13039\/501100010760","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.bioorg.2026.109615","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T16:01:48Z","timestamp":1770307308000},"page":"109615","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Strategic engineering of imidazopyridine-benzoxazole hybrids targeting microtubule dynamics: comprehensive inhibition of the metastatic cascade"],"prefix":"10.1016","volume":"172","author":[{"given":"Burak","family":"Kuzu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Cakir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eda","family":"Acikgoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bioorg.2026.109615_bb0005","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.gendis.2022.02.007","article-title":"Cancer chemotherapy and beyond: current status, drug candidates, associated risks and progress in targeted therapeutics","volume":"10","author":"Anand","year":"2023","journal-title":"Genes & diseases"},{"key":"10.1016\/j.bioorg.2026.109615_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.891652","article-title":"Multidrug resistance in cancer: understanding molecular mechanisms, immunoprevention and therapeutic approaches","volume":"12","author":"Emran","year":"2022","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109615_bb0015","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41392-024-01856-7","article-title":"Exploring treatment options in cancer: tumor treatment strategies","volume":"9","author":"Liu","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bioorg.2026.109615_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.969183","article-title":"The microtubule cytoskeleton: an old validated target for novel therapeutic drugs","volume":"13","author":"Lafanech\u00e8re","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109615_bb0025","article-title":"Stabilizing versus destabilizing the microtubules: A double-edge sword for an effective Cancer treatment option?","volume":"2015","author":"Fanale","year":"2015","journal-title":"Anal. Cell. Pathol."},{"issue":"5","key":"10.1016\/j.bioorg.2026.109615_bb0030","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/s44321-025-00223-5","article-title":"Beyond mitotic arrest: the diverse effects of microtubule-targeting drugs on tumor vasculature","volume":"17","author":"Risinger","year":"2025","journal-title":"EMBO Mol. Med."},{"issue":"16","key":"10.1016\/j.bioorg.2026.109615_bb0035","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.3390\/molecules30163314","article-title":"Recent advances in microtubule targeting agents for Cancer therapy","volume":"30","author":"Assun\u00e7\u00e3o","year":"2025","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.bioorg.2026.109615_bb0040","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/ph13010008","article-title":"Colchicine-binding site inhibitors from chemistry to clinic: a review","volume":"13","author":"McLoughlin","year":"2020","journal-title":"Pharmaceuticals"},{"issue":"11","key":"10.1016\/j.bioorg.2026.109615_bb0045","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1007\/s11095-012-0828-z","article-title":"An overview of tubulin inhibitors that interact with the colchicine binding site","volume":"29","author":"Lu","year":"2012","journal-title":"Pharm. Res."},{"issue":"4","key":"10.1016\/j.bioorg.2026.109615_bb0050","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/S0002-9440(10)63398-6","article-title":"The tubulin-binding agent combretastatin A-4-phosphate arrests endothelial cells in mitosis and induces mitotic cell death","volume":"165","author":"Kanthou","year":"2004","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.bioorg.2026.109615_bb0055","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.3390\/molecules28041717","article-title":"Development of combretastatin A-4 analogues as potential anticancer agents with improved aqueous solubility","volume":"28","author":"Chen","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.109615_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111732","article-title":"Design, synthesis, and biological evaluation of 1-substituted-2-aryl imidazoles targeting tubulin polymerization as potential anticancer agents","volume":"184","author":"Li","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"23","key":"10.1016\/j.bioorg.2026.109615_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127608","article-title":"Computational modeling and target synthesis of monomethoxy-substituted o-diphenylisoxazoles with unexpectedly high antimitotic microtubule destabilizing activity","volume":"30","author":"Stroylov","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"9","key":"10.1016\/j.bioorg.2026.109615_bb0070","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.1021\/jm049096o","article-title":"Synthesis and cytotoxic evaluation of combretafurazans","volume":"48","author":"Tron","year":"2005","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2026.109615_bb0075","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1021\/acsmedchemlett.3c00298","article-title":"Fused imidazopyrazine-based tubulin polymerization inhibitors inhibit neuroblastoma cell function","volume":"14","author":"Thammathong","year":"2023","journal-title":"ACS Med. Chem. Lett."},{"issue":"17","key":"10.1016\/j.bioorg.2026.109615_bb0080","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.2174\/0929867033457151","article-title":"Combretastatin A-4 analogues as antimitotic antitumor agents","volume":"10","author":"Nam","year":"2003","journal-title":"Curr. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2026.109615_bb0085","doi-asserted-by":"crossref","first-page":"496","DOI":"10.26650\/IstanbulJPharm.2024.1436292","article-title":"Imidazopyridine scaffold as an effective tubulin polymerization inhibitor","volume":"54","author":"Kuzu","year":"2024","journal-title":"\u0130stanbul J. Pharmacy"},{"issue":"11","key":"10.1016\/j.bioorg.2026.109615_bb0090","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.3390\/molecules29112668","article-title":"Imidazopyridine family: versatile and promising heterocyclic skeletons for different applications","volume":"29","author":"Volpi","year":"2024","journal-title":"Molecules"},{"issue":"24","key":"10.1016\/j.bioorg.2026.109615_bb0095","doi-asserted-by":"crossref","first-page":"14279","DOI":"10.1080\/07391102.2021.1997818","article-title":"Imidazopyridine, a promising scaffold with potential medicinal applications and structural activity relationship (SAR): recent advances","volume":"40","author":"Khatun","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"7","key":"10.1016\/j.bioorg.2026.109615_bb0100","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1021\/jm101582z","article-title":"Design and synthesis of imidazopyridine analogues as inhibitors of phosphoinositide 3-kinase signaling and angiogenesis","volume":"54","author":"Kim","year":"2011","journal-title":"J. Med. Chem."},{"issue":"24","key":"10.1016\/j.bioorg.2026.109615_bb0105","doi-asserted-by":"crossref","first-page":"7677","DOI":"10.1016\/j.bmc.2007.08.062","article-title":"Synthesis, biological evaluation and molecular modelling of sulfonohydrazides as selective PI3K p110\u03b1 inhibitors","volume":"15","author":"Kendall","year":"2007","journal-title":"Bioorg. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2026.109615_bb0110","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1039\/c0md00116c","article-title":"Design, synthesis and biological evaluation of imidazopyridine\/pyrimidine-chalcone derivatives as potential anticancer agents","volume":"1","author":"Kamal","year":"2010","journal-title":"MedChemComm"},{"issue":"3","key":"10.1016\/j.bioorg.2026.109615_bb0115","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.ejmech.2009.11.049","article-title":"6-substituted 2-(N-trifluoroacetylamino) imidazopyridines induce cell cycle arrest and apoptosis in SK-LU-1 human cancer cell line","volume":"45","author":"Mart\u00ednez-Urbina","year":"2010","journal-title":"Eur. J. Med. Chem."},{"issue":"15","key":"10.1016\/j.bioorg.2026.109615_bb0120","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1016\/j.bmcl.2018.06.033","article-title":"Synthesis of novel imidazopyridines and their biological evaluation as potent anticancer agents: A promising candidate for glioblastoma","volume":"28","author":"G\u00fc\u00e7l\u00fc","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.109615_bb0125","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.ejmech.2016.12.026","article-title":"Structure-based design and synthesis of imidazo [1, 2-a] pyridine derivatives as novel and potent Nek2 inhibitors with in vitro and in vivo antitumor activities","volume":"126","author":"Xi","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2026.109615_bb0130","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1002\/cmdc.201300308","article-title":"Synthesis and biological evaluation of imidazopyridine\u2013oxindole conjugates as microtubule-targeting agents","volume":"8","author":"Kamal","year":"2013","journal-title":"ChemMedChem"},{"issue":"48","key":"10.1016\/j.bioorg.2026.109615_bb0135","doi-asserted-by":"crossref","first-page":"9864","DOI":"10.1039\/C4OB01930J","article-title":"Synthesis and biological evaluation of imidazo [1, 5-a] pyridine-benzimidazole hybrids as inhibitors of both tubulin polymerization and PI3K\/Akt pathway","volume":"12","author":"Kamal","year":"2014","journal-title":"Org. Biomol. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2026.109615_bb0140","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1039\/C4MD00400K","article-title":"Design, synthesis and biological evaluation of imidazopyridine\/imidazopyrimidine-benzimidazole conjugates as potential anticancer agents","volume":"6","author":"Kamal","year":"2015","journal-title":"MedChemComm"},{"issue":"6","key":"10.1016\/j.bioorg.2026.109615_bb0145","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1039\/C3MD00357D","article-title":"Combretastatin A-4 inspired novel 2-aryl-3-arylamino-imidazo-pyridines\/pyrazines as tubulin polymerization inhibitors, antimitotic and anticancer agents","volume":"5","author":"Sanghai","year":"2014","journal-title":"MedChemComm"},{"key":"10.1016\/j.bioorg.2026.109615_bb0150","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejmech.2014.09.051","article-title":"Recent developments in tubulin polymerization inhibitors: an overview","volume":"87","author":"Kaur","year":"2014","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2026.109615_bb0155","doi-asserted-by":"crossref","DOI":"10.1002\/mog2.46","article-title":"Microtubule-targeting agents for cancer treatment: seven binding sites and three strategies","volume":"2","author":"Wang","year":"2023","journal-title":"MedComm\u2013Oncology"},{"key":"10.1016\/j.bioorg.2026.109615_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bioorg.2017.10.019","article-title":"Synthesis of benzo [d] imidazo [2, 1-b] thiazole-chalcone conjugates as microtubule targeting and apoptosis inducing agents","volume":"76","author":"Sultana","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109615_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107839","article-title":"A potent bioorganic azapodophyllotoxin derivative suppresses tumor progression in triple negative breast cancer: an insight into its inhibitory effect on tubulin polymerization and disruptive effect on microtubule assembly","volume":"153","author":"Gupta","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"31","key":"10.1016\/j.bioorg.2026.109615_bb0170","doi-asserted-by":"crossref","first-page":"21744","DOI":"10.18632\/oncotarget.24934","article-title":"Camptothecin induces G2\/M phase arrest through the ATM-Chk2-Cdc25C axis as a result of autophagy-induced cytoprotection: implications of reactive oxygen species","volume":"9","author":"Jayasooriya","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.bioorg.2026.109615_bb0175","first-page":"498","article-title":"Targeting mitosis in cancer: emerging strategies","volume":"15","author":"Dominguez-Brauer","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bioorg.2026.109615_bb0180","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nrc.2016.138","article-title":"Cell cycle proteins as promising targets in cancer therapy","volume":"17","author":"Otto","year":"2017","journal-title":"Nat. Rev. Cancer"},{"issue":"51","key":"10.1016\/j.bioorg.2026.109615_bb0185","doi-asserted-by":"crossref","first-page":"6726","DOI":"10.1039\/C4CC02425G","article-title":"A one-pot hypoiodite catalysed oxidative cycloetherification approach to benzoxazoles","volume":"50","author":"Kumar\u00e1Boominathan","year":"2014","journal-title":"Chem Comm"},{"key":"10.1016\/j.bioorg.2026.109615_bb0190","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1007\/s11696-025-03947-3","article-title":"Imidazo[1,2-a]pyridine mannich bases: synthesis, anticholinesterase evaluation, and in silico studies","volume":"79","author":"Kuzu","year":"2025","journal-title":"Chem. Pap."},{"issue":"3","key":"10.1016\/j.bioorg.2026.109615_bb0195","doi-asserted-by":"crossref","DOI":"10.1111\/cbdd.70078","article-title":"Pyrrole-tethered bisbenzoxazole derivatives: apoptosis-inducing agents targeting breast cancer cells","volume":"105","author":"Kuzu","year":"2025","journal-title":"Chem. Biol. Drug Des."},{"issue":"5","key":"10.1016\/j.bioorg.2026.109615_bb0200","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s11094-025-03427-8","article-title":"Synthesis, Antiproliferative activity, and pre-Admet studies of P-Aminophenyl substituted Benzoxazole derivatives designed based on Phortress","volume":"59","author":"Erg\u00fc\u00e7","year":"2025","journal-title":"Pharm. Chem. J."},{"issue":"17","key":"10.1016\/j.bioorg.2026.109615_bb0205","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202500320","article-title":"Unveiling Benzoxazole-substituted Thiazolyl-Pyrazole derivatives inducing apoptosis by targeting \u03b2-tubulin and Caspase-3","volume":"20","author":"Kuzu","year":"2025","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2026.109615_bb0210","doi-asserted-by":"crossref","unstructured":"\u00c7ak\u0131r, M., Akar, S., \u00c7ak\u0131r, \u015e., Akko\u00e7, S., Ozkol, H., & T\u00fcl\u00fcce, Y. Anticancer effect of 1-(Anthracen-10-ylmethyl)-3-(2-cyanobenzyl)-1H-benzo [d] imidazol-3-ium chloride in 2D and 3D cell culture models in breast cancer. East. J. Med., 29(2), 244\u2013251.","DOI":"10.5505\/ejm.2024.03708"},{"key":"10.1016\/j.bioorg.2026.109615_bb0215","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3389\/fcell.2019.00107","article-title":"In vitro cell migration, invasion, and adhesion assays: from cell imaging to data analysis","volume":"7","author":"Pijuan","year":"2019","journal-title":"Front. Cell Developmental Biol."},{"key":"10.1016\/j.bioorg.2026.109615_bb0220","series-title":"Extracellular Matrix Protocols: Second Edition","first-page":"203","article-title":"Cell adhesion assays","author":"Humphries","year":"2009"},{"key":"10.1016\/j.bioorg.2026.109615_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.138199","article-title":"Design, synthesis, and applications of nucleic acid-specific benzoxazole-N, N-dialkylphenylamines derivatives for nucleolus imaging in the cells","volume":"1309","author":"Kuzu","year":"2024","journal-title":"J. Mol. Struct."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826001513?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826001513?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T20:58:00Z","timestamp":1784753880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826001513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":45,"alternative-id":["S0045206826001513"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109615","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Strategic engineering of imidazopyridine-benzoxazole hybrids targeting microtubule dynamics: comprehensive inhibition of the metastatic cascade","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109615","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109615"}}